{"disease":{"id":"ulcer-of-esophagus","name":"Ulcer of esophagus","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"carbenoxolone","indication_name":"Ulcer of esophagus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Biogastrone","generic_name":"CARBENOXOLONE","company_name":"","drug_phase":"phase_2","molecular_target":"Corticosteroid 11-beta-dehydrogenase isozyme 1","drug_class":"carbenoxolone","quality_score":null,"revenue":null,"mechanism":"Biogastrone works by inhibiting the enzyme that converts cortisol into a more potent form, reducing inflammation in the stomach and esophagus."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}